Acute EBV Rash Expanded Beyond the Expected Antibiotic Pattern
A man in his late 20s developed a widespread maculopapular eruption during infectious mononucleosis after exposure to multiple antibiotics, and the rash ultimately spread to the palms and soles. The distribution immediately widened the differential beyond a routine viral exanthem. Secondary syphilis, drug hypersensitivity, and an EBV-associated antibiotic rash all entered the picture, each carrying different implications for treatment, future antibiotic use, and patient counseling.
EBV infection is already a familiar source of diagnostic confusion because it can present with fever, pharyngitis, and lymphadenopathy while also producing laboratory abnormalities that look inflammatory and systemic. Skin findings add another layer of complexity. When antibiotics enter the story, especially beta-lactams, the probability of a drug-related eruption rises in the mind of any clinician seeing the patient at the bedside. In this case, sequential antibiotic exposure made attribution particularly difficult, because no single drug exposure neatly explained the full clinical course.
The rash did not remain confined to a nonspecific truncal exanthem. Palmar and plantar involvement sharpened concern for secondary syphilis, a classic mimic that demands deliberate exclusion when generalized rash and systemic symptoms overlap. A drug hypersensitivity reaction remained equally plausible, especially given the antibiotic history and the inflammatory laboratory pattern. In practice, the bedside problem was not simply naming the rash; it was determining whether the eruption represented a transient EBV-related immune phenomenon, a true antimicrobial allergy, or an unrelated infectious process requiring a different diagnostic path.
Laboratory Findings Narrowed the Differential Without Fully Settling It
Investigations showed marked lymphocytosis, elevated inflammatory markers, and deranged liver enzymes. Those findings fit comfortably with acute EBV infection, where hematologic and hepatic abnormalities commonly accompany the clinical syndrome. A negative throat culture for beta-hemolytic streptococci and an antistreptolysin O titer that did not suggest recent streptococcal infection helped move streptococcal disease out of the foreground. Treponema pallidum antibody testing was negative, which weakened the concern for secondary syphilis, while measles PCR was also negative.
The diagnostic workup mattered because palmoplantar rash can trigger reflexive narrowing toward a single infectious diagnosis. Here, however, the data pointed in several directions at once. The blood count and liver chemistry pattern supported a systemic viral illness, yet the rash timing after antibiotics kept drug hypersensitivity in play. EBV PCR and repeat serology later supported acute EBV infection, making the viral explanation more coherent than the initial bedside impression. Even so, the antibiotic exposures could not be ignored, because antibiotic-associated eruptions in EBV are well recognized and often create uncertainty about future penicillin tolerance.
One sentence captured the core problem: the rash looked like more than one disease at once.
Sequential Antibiotics Complicated Causality Assessment
Retrospective review identified prior intravenous amoxicillin exposure during an admission for appendicitis, adding another layer of ambiguity to the eruption. Sequential antibiotic exposure weakens any simple cause-and-effect narrative. A rash that appears after one antibiotic might be blamed on that agent, but a prior or subsequent exposure can alter the immune context and make causal inference unreliable. For clinicians, this creates a familiar trap: a patient may leave with a lifelong penicillin allergy label based on a reaction that was actually part of the EBV illness itself.
In EBV, antibiotic-associated exanthems are clinically important because the visual pattern can be alarming while the underlying process is often self-limited once the acute infection resolves. Yet the distinction between benign exanthem and true hypersensitivity cannot be assumed. The stakes are practical and immediate. A mislabeled allergy can limit future antimicrobial choices, increase use of broader-spectrum agents, and complicate care long after the acute illness has passed.
This case also shows how a palmoplantar eruption can distort diagnostic thinking. Once the hands and feet are involved, clinicians must consider infections that carry public health and sexual health implications, not just common drug reactions. The workup therefore needed to exclude syphilis and measles while still accounting for the EBV syndrome itself. The breadth of testing reflected the breadth of the differential, not diagnostic overreach.
Conservative Care Was Followed by Clinical and Biochemical Recovery
The patient improved with conservative management, and the rash resolved along with normalization of the white cell count and liver enzymes at follow-up. That recovery pattern supports a self-limited process rather than a progressive inflammatory drug syndrome or another untreated systemic infection. The favorable outcome also fits the natural course of acute EBV in many otherwise healthy adults, where symptoms gradually ease as immune activation recedes.
Recovery did not remove the clinical lesson. It clarified the importance of careful antibiotic history, especially when sequential agents are prescribed around the time of viral illness. It also reinforced the need to review prior exposures before assigning a penicillin allergy label. In a patient whose rash emerged during EBV infection, the label may reflect immune cross-reactivity, transient intolerance, or a genuine drug hypersensitivity, and those possibilities are not interchangeable.
A negative syphilis test and negative measles PCR mattered because they kept the differential anchored to the actual evidence rather than the appearance of the rash alone. Palmoplantar involvement can be visually dramatic, but dramatic morphology does not equal diagnostic certainty. The laboratory trajectory, the repeated virologic evaluation, and the clinical improvement together favored acute EBV with an associated exanthem after antibiotic exposure.
Antibiotic Allergy Labels Require More Than a Rash Description
This case is most useful at the point of future prescribing. A patient who develops a rash during EBV infection after amoxicillin or other antibiotics may later be treated as permanently allergic unless the episode is carefully interpreted. That outcome has consequences. Penicillin-class avoidance can push clinicians toward broader, less targeted therapy and can shape care for years after the initial illness. Accurate history-taking and, when appropriate, formal reassessment of suspected penicillin allergy are essential to avoid that downstream harm.
The case also illustrates a more general clinical principle: rash in EBV is not a single entity. Some eruptions are linked to the infection itself, some are temporally related to antibiotics, and some are indistinguishable at presentation without laboratory support and follow-up. The palmoplantar distribution, the lymphocytosis, the elevated liver enzymes, and the eventual improvement all belonged to the same evolving diagnostic puzzle. Sorting out that puzzle required exclusion of alternative infections, recognition of the antibiotic timeline, and restraint before fixing a permanent allergy label.
For clinicians, the most consequential detail may be the least dramatic one. The eruption resolved, but the prescribing record could have outlasted it by years.